CCL2 and neoplasm: Blockade of CCR2 signaling with Abs or small molecules targeting either CCR2 or CCL2 reduces tumor growth or metastasis in mouse models of breast,2 lung,120 pancreatic,72, 76 liver,73 and prostate121 cancers.